An announcement from GlaxoSmithKline ( (GB:GSK) ) is now available.
GSK plc announced the purchase of 724,000 of its own ordinary shares, as part of its ongoing buyback program, executed through Citigroup Global Markets Limited. The shares, bought at a volume-weighted average price of 1,525.77 pence, will be held as treasury shares, contributing to a total of 177,331,345 shares in treasury. This move is part of a strategic effort to manage the company’s capital structure and enhance shareholder value.
More about GlaxoSmithKline
GlaxoSmithKline (GSK) is a global healthcare company operating in the pharmaceutical industry, focusing on the development and production of medicines, vaccines, and consumer healthcare products. The company is known for its commitment to improving the quality of human life by enabling people to do more, feel better, and live longer.
YTD Price Performance: 13.86%
Average Trading Volume: 8,263,182
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: £61.77B
See more insights into GSK stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com